20th Clinical Trials Innovation Programme: October 26 – 27, 2022

Join World BI and Redenlab for the 20th Clinical Trials Innovation Programme, to learn from experts in the drug development industry.

Hear from CEO Dr Adam Vogel and other leading industry experts exploring the future of clinical trials, patient centricity, and drug development digitalisation post COVID. 26 – 27 October 2022, Boston.

To find out more and register, click here.

Related Post

Speech, Language and Non-verbal Communication in CLN2 and CLN3 Batten Disease

  • Posted on 18 February, 2025
    Batten disease, or neuronal ceroid lipofuscinosis (NCL), is a devastating childhood dementia that causes progressive loss of speech, language, and...
    Read more

    View all publications by Redenlab

    • Posted on 18 February, 2025
      Redenlab is dedicated to advancing research in the field of speech, language, and cognitive disorders, particularly in the context of...
      Read more

      Aphasia resulting from dementia is a debilitating aspect of the disease. Difficulty communicating has widespread impacts for patients and their network

      • Posted on 28 January, 2025
        Researchers at University of Texas at Austin have developed a behavioral therapy designed to improve communication in individuals with primary...
        Read more